Search - tctmd.com

Displaying 21 - 40 of 46

Sort: Relevancy | Date

News Daily News

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Yael L. Maxwell

August 24, 2017

News Daily News

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Ashley Lyles

August 07, 2017

News Daily News

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

L.A. McKeown

July 20, 2017

News Daily News

No Racial Disparity in Post-PCI Mortality Seen at the VA

Todd Neale

July 19, 2017

News Daily News

Highs and Lows: Contrast Volume in PCI Varies Greatly Among US Physicians

Caitlin E. Cox

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Yael L. Maxwell

May 22, 2017

Presentation EuroPCR 2017

Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management

Presenter: Bernando Cortese

May 19, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News ACC 2017

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

Todd Neale

March 19, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Daily News

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Michael O'Riordan

March 16, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

Advertisement

After Failed Mitral Valve Surgery, Transcatheter Valve-in-Valve or Valve-in-Ring Shows Promise in High-Risk Patients

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Higher In-Hospital Mortality After STEMI Linked to Lack of Health Insurance

No Racial Disparity in Post-PCI Mortality Seen at the VA

Highs and Lows: Contrast Volume in PCI Varies Greatly Among US Physicians

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting

Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Cerebral Embolic Protection During Surgical AVR Fails to Show a Benefit

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Timing and Dose Matters When It Comes to Statin Therapy Before CABG Surgery

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content